-
China launches project to promote use of AI in scitech research
www.gov.cn
March 28, 2023
China has started the deployment of Artificial Intelligence for Science, a project to promote the use of AI in frontier sci-tech research.
-
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
PharmaSources
March 16, 2023
Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables.
-
CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development
AmericanPharmaceuticalReview
February 15, 2022
CytoReason announced the extension of its collaboration agreement with Pfizer.
-
6th China-ASEAN Summit for Drug Development and Cooperation opens in Guangxi
NMPA
September 22, 2021
Co-sponsored by China's National Medical Products Administration (NMPA) and the government of the Guangxi Zhuang autonomous region, the Sixth China-ASEAN Summit...
-
CPhI Webinar: Trends and Advances in Patient Centric Drug Development - Watch On Demand
cphi-online
June 24, 2021
Catch up on the latest trends and developments in patient centric drug development
-
Syneos Expands Decentralized Trial Capabilities
contractpharma
June 23, 2021
Syneos Health expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, as part of its continuing efforts to move clinical trials closer to the patient.
-
New research could allow bioproduction of toxic compounds
europeanpharmaceuticalreview
April 27, 2021
A paper shows implementing riboregulated switchable feedback promoters enables cells to produce the precursors for potentially toxic chemotherapeutic and anti-malarial drugs.
-
Astellas Establishes Global Patient Centricity Leadership Structure
americanpharmaceuticalreview
October 09, 2020
Astellas announced the structure and operating model for its global Patient Centricity organization designed to support the development of innovative health solutions.
-
PPD, Pfizer Ink New Service Pact
contractpharma
August 04, 2020
PPD to provide drug development services to advance Pfizer’s portfolio under new three-year agreement.
-
Rentschler, Horizon Ink Cell Line Development Pact
contractpharma
May 20, 2020
The alliance aims to drive efficiencies in biotherapeutic manufacturing from early drug development through commercial manufacturing.